ACUR Description — Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals is a pharmaceutical company engaged in the research, development and commercialization of technologies and products focusing on medication abuse and misuse. Co. has three proprietary platform technologies: Limitx technology focuses on abuse by excess oral consumption of multiple tablets and provide a margin of safety during accidental over-ingestion of tablets; Aversion Technology incorporates gelling ingredients and irritants into tablets to discourage abuse by snorting and provide barriers to abuse by injection; Oxaydo Tablets, Oxaydo (oxycodone HCI tablets) is a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain.